Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2018-2023
Historical Year
2024-2032
Forecast Year
Global Vaccine Companies
The prevalence of cancer is bolstering the demand for novel cancer vaccines. In September 2023 , Moderna (a biotech company in the United States) and Immatics (a transatlantic organization biopharmaceutical company) announced a strategic collaboration to develop oncology therapeutics including cancer vaccines by utilizing Moderna’s mRNA technology and Immatics’ XPRESIDENT® target discovery platform. Under the terms of the agreement, Immatics will receive USD 120 million along with research funding and royalty payments. The collaboration is predicted to cater to the unmet medical needs of cancer patients by developing innovative cancer immunotherapies.
The key features of the vaccine market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Merck & Co. Inc.
- GlaxoSmithKline Plc
- Sanofi Aventis
- Novartis AG
- Pfizer Inc.
- Takeda Pharmaceutical Company Limited
- DAIICHI SANKYO COMPANY, LIMITED
- Mitsubishi Chemical Group Corporation
- AstraZeneca
- MASSACHUSETTS BIOTECHNOLOGY COUNCIL
- Biokangtai
- Serum Institute of India Pvt. Ltd
- VBI Vaccines Inc
- Fei Biological
- Indian Immunologicals Ltd.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Vaccine Market Report Snapshots
Vaccine Market Regional Analysis
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The market attained a value of about USD 68.07 billion in 2023, driven by the rising prevalence of infectious diseases across the globe.
The market is anticipated to grow at a CAGR of 10.5% during the forecast period of 2024-2032, likely to reach a market value of USD 167.19 billion by 2032.
The market demand is driven by substantial improvements in the healthcare infrastructure and increased awareness about the effectiveness of vaccines in preventing diseases.
The emphasis on treating chronic diseases with the help of vaccinations is a key market trend. In April 2023, a Norwegian biotechnology company, Nykode Therapeutics announced that its cervical cancer vaccine, VB10.16, showed increased survival in advanced cervical cancer patients in a Phase IIa clinical trial.
The market is divided into pneumococcal, influenza, DTP, HPV, MMR, and COVID-19.
The various end users of vaccines include adults and children.
Recombinant, toxoid, conjugate, and RNA among others, are the vaccine technologies available in the market.
The various distribution channels include hospital and clinical pharmacies, retail pharmacies, and online pharmacies, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
Key players involved in the market are Merck & Co. Inc., GlaxoSmithKline Plc, Sanofi Aventis, Novartis AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, DAIICHI SANKYO COMPANY, LIMITED, Mitsubishi Chemical Group Corporation, AstraZeneca, MASSACHUSETTS BIOTECHNOLOGY COUNCIL, Biokangtai, Serum Institute of India Pvt. Ltd., VBI Vaccines Inc., Fei Biological and Indian Immunologicals Ltd.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
- Our Insights Store:
-
Industry Statistics
-
Procurement Insights
-
Consumer Insights
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124